![Gaurav Aggarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gaurav Aggarwal
Private Equity Investor chez
Vivo Capital LLC
Fortune : 2 935 $ au 31/08/2026
Profil
Gaurav Aggarwal is Managing Partner at Vivo Capital LLC since 2024.
Former roles include Independent Director at Sierra Oncology, Inc. from 2019 to 2022; Independent Director at Geron Corp.
from 2023 to 2025; Independent Director at Unicycive Therapeutics, Inc. from 2023 to 2026; Chief Business Officer at OCERA Therapeutics LLC and Ocera Therapeutics, Inc. from 2014 to 2016; Director at Hyperion Therapeutics, Inc. from 2009 to 2013; Managing Director at Patricia Industries AB in 2013; Associate at J.P.
Morgan Partners LLC from 2004 to 2006; Vice President at KBL Healthcare Ventures from 2000 to 2004; Principal at Panorama Capital LLC from 2006 to 2011; Principal at Wasserstein Perella & Co., Inc. in 1998; Managing Director at Investor Growth Capital Asia Ltd.; and Director at Vela Pharmaceuticals, Inc., Piramed Ltd., Alvine Pharmaceuticals, Inc., NextWave Pharmaceuticals, Inc., Microlin Bio, Inc., FlowCardia, Inc., and Auspex Pharmaceuticals, Inc. Education includes an undergraduate degree from Cornell University in 1994 and a doctorate from Columbia University College of Physicians & Surgeons in 2000.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2025 | 1 970 ( 0 % ) | 2 935 $ | 31/08/2026 |
Postes actifs de Gaurav Aggarwal
| Sociétés | Poste | Début |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Private Equity Investor | 01/10/2016 |
Anciens postes connus de Gaurav Aggarwal
| Sociétés | Poste | Fin |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/04/2026 |
| GERON CORPORATION | Directeur/Membre du Conseil | 10/10/2025 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/07/2022 |
| OCERA THERAPEUTICS INC | Corporate Officer/Principal | 07/10/2016 |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for gastrointestinal and liver diseases | Corporate Officer/Principal | 01/10/2016 |
Formation de Gaurav Aggarwal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Finance |
Vela Pharmaceuticals, Inc.
 Vela Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines related to the nervous system | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services Develops drugs, diagnostics, and other therapeutic products | Commercial Services |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Operates as a pre-clinical stage biopharmaceutical company | Health Technology |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Finance |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBL Healthcare Ventures
 KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements. | Finance |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures endovascular devices | Health Technology |
Investor Growth Capital Asia Ltd.
 Investor Growth Capital Asia Ltd. Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Asia specializes in expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $15 million. They also takes board seat and controlling shares. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage. | Finance |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Finance |
Ocera Therapeutics, Inc. /Old/
Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for gastrointestinal and liver diseases | Health Technology |
Wasserstein Perella & Co., Inc.
 Wasserstein Perella & Co., Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Patricia Industries AB
 Patricia Industries AB Investment ManagersFinance Patricia Industries invests in companies located in the Nordic region and North America. The firm focuses on a broad range of sectors and industries. It provides financing for buyout capital transactions. | Finance |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unicycive Therapeutics, Inc.
 Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
